Header cover image

Belgian Biotech Stocks

Results

3

0 new
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

3 companies

argenx

Market Cap: €32.7b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€536.80

7D

-2.7%

1Y

48.2%

UCB

Market Cap: €30.6b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

UCB

€160.85

7D

-3.2%

1Y

38.2%

European Medical Solutions

Market Cap: €20.5m

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.

ALEMS

€4.83

7D

-13.1%

1Y

-31.4%

Page 1 of 1